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Background: Biotransformation of organic compounds by using microbial whole cells provides an efficient
approach to obtain novel analogues which are often difficult to synthesize chemically. In this manuscript, we report
for the first time the microbial transformation of a synthetic anabolic steroidal drug, oxymetholone, by fungal cell
cultures.
Results: Incubation of oxymetholone (1) with Macrophomina phaseolina, Aspergillus niger, Rhizopus stolonifer, and
Fusarium lini produced 17β-hydroxy-2-(hydroxy-methyl)-17α-methyl-5α-androstan-1-en-3-one (2), 2α,17α-di(hydroxyl-
methyl)-5α-androstan-3β,17β-diol (3), 17α-methyl-5α-androstan-2α,3β,17β-triol (4), 17β-hydroxy-2-(hydroxymethyl)-
17α-methyl-androst-1,4-dien-3-one (5), 17β-hydroxy-2α-(hydroxy-methyl)-17α-methyl-5α-androstan-3-one (6), and
2α-(hydroxymethyl)-17α-methyl-5α-androstan-3β-17β-diol (7). Their structures were deduced by spectral analyses, as
well as single-crystal X-ray diffraction studies. Compounds 2–5 were identified as the new metabolites of 1. The
immunomodulatory, and anti-inflammatory activities and cytotoxicity of compounds 1–7 were evaluated by
observing their effects on T-cell proliferation, reactive oxygen species (ROS) production, and normal cell growth in
MTT assays, respectively. These compounds showed immunosuppressant effect in the T-cell proliferation assay with
IC50 values between 31.2 to 2.7 μg/mL, while the IC50 values for ROS inhibition, representing anti-inflammatory
effect, were in the range of 25.6 to 2.0 μg/mL. All the compounds were found to be non-toxic in a cell-based
cytotoxicity assay.
Conclusion: Microbial transformation of oxymetholone (1) provides an efficient method for structural
transformation of 1. The transformed products were obtained as a result of de novo stereoselective reduction of the
enone system, isomerization of double bond, insertion of double bond and hydroxylation. The transformed
products, which showed significant immunosuppressant and anti-inflammatory activities, can be further studied for
their potential as novel drugs.
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Microbial regio- and stereo-selective transformations of ster-
oids have been extensively investigated [1, 2]. We have been
studying microbial transformation of bioactive steroids with
the objectives of producing their novel metabolites and
understanding their metabolism [3–8]. Oxymetholone [17β-
hydroxy-2-(hydroxymethylene)-17α-methyl-5α-androstan-3-
one, C21H32O3] (1), a 17α-alkylated anabolic-androgenic
steroid, has been approved by the US Food and Drug
Administration for the treatment of blood anemia, osteopor-
osis, HIV-associated wasting, antithrombin III deficiency,
pediatric growth impairment, and damaged myocardium;
as well as for stimulating muscle growth in malnourished,
and underdeveloped individuals. However, it is also been
abused by some athletes for enhancing muscle mass and
strength [9, 10]. Compound 1 also known to exhibit im-
munosuppressant activity in vivo by decreasing the activity
of T-cells [11].
During current study, compound 1 was found to exhibit
significant immunomodulatory and anti-inflammatory activ-
ities in vitro in T-cell proliferation and reactive oxygen spe-
cies (ROS) production assay, respectively. T-Lymphocytes
play a key role in cell mediated immune response by activat-
ing various T-cells and modulating autoimmune response.
Thus inhibition of T-cell proliferation can serve as an ap-
proach to treat various immune disorders [12], including
organ rejection after transplant [13]. The immune system
also utilizes various cellular processes for elimination of
pathogens, such as phagocytosis which involves elimination
of pathogens by enzyme catalyzed oxidative burst. Ironically
prolonged overproduction of ROS can damage body’s own
cells and tissues, and lead to chronic inflammation and
other autoimmune diseases [14].
Based on these preliminary findings, we investigated
biotransformation of 1 to obtain new analogues. Prelimin-
ary experiments showed that Macrophomina phaseolina,
Aspergillus niger, Rhizopus stolonifer, and Fusarium lini can
efficiently transform 1 into several metabolites. Subsequent
large scale fermentation was carried out and four new
metabolites 2–5, along with two known metabolites 6 and
7 were obtained. The structures of new metabolites were
unambiguously deduced through 1D- and 2D-NMR and by
single-crystal X-ray diffraction techniques. Metabolites 2–7
were then evaluated for the inhibition of T-cell proliferation
(IC50 values in the range of 31.2 to 2.7 μg/mL), and ROS
production (1 and 2 had a strong inhibition (IC50 = 2 to
2.3 μg/mL)), representing their immunosuppressant and
anti-inflammatory potential.
Results and discussion
Structure elucidation of metabolites
Incubation of oxymetholone (1) (C21H32O3) with Macro-
phomina phaseolina, Aspergillus niger, Rhizopus stolonifer
and Fusarium lini produced six metabolites 2–7 (Figure 1).Metabolites 6 and 7 were previously obtained through
chemical hydrogenation of 1 [15], however this is the first
report of their biomimetic synthesis. The structures of
new metabolites 2–5 were unambiguously deduced largely
by single-crystal X-ray diffraction analyses.
The HREI-MS [M+ =m/z 332.2333 (calcd 332.2351)
(C21H32O3)], IR (1666 cm
-1) and UV (236.4 nm) spectra
of 2 suggested the C = C isomerization of 1 into 2 [8,
16]. The 1H- and 13C-NMR spectra (Table 1) showed a
new olefinic methine H/C signal at δ 6.48/δ 152.4, along
with a hydroxyl-bearing methylene H2/C at δ 4.78 and
4.76 (J21a,b = 15.0 Hz)/δ 59.8 for HC-1 and H2C-21, re-
spectively. Me (19) protons (δ 0.96) were correlated with
C-1 (δ 152.4) in HMBC, while C-21 protons (δ 4.78,
4.76) were correlated with C-1 (δ 152.4) and C-2 (δ
137.5). Additionally, C-1 (δ 6.48) and C-4 protons (δ
2.47, 2.26) were also correlated with C-3 (δ 199.0), and
C-2 (δ 137.5) C-1 Proton also showed HMBC correla-
tions with C-21 (δ 59.8). The structure of new metabol-
ite 2 was finally deduced through single-crystal X-ray
diffraction techniques (Figure 2). The asymmetric unit
contains two independent molecules of metabolite
2. The ORTEP diagrams of 2 (Figure 2) showed four
trans fused rings A, B, C, and D with half chair/chair/
chair, and envelop conformations, respectively. C-17 -OH
and methyl groups exist in pseudo-equatorial and pseudo-
axial orientations, respectively. The shorter bond lengths
of C-2—C-3 single-bond (1.476(8) Å) is due to the conju-
gation of C-1—C-2 (1.321(7) Å) olefinic bond with the
C-3 carbonyl moiety. All bond angles and lengths were
within the normal range.
The UV inactive metabolite 3 showed molecular ion
(M+) at m/z 352.2643 (calcd 352.2613), in agreement
with the formula C21H36O4, indicating reduction of C =
C bond and addition of any oxygen. The 1H- and 13C-
NMR spectra of 3 (Table 1) showed two pairs of down-
field OH-bearing methylene H2/C signals at δ 4.09, 3.82
(d, J20a,b = 10.3 Hz)/δ 67.3 (H2C-20) and 4.17, 4.03 (m)/δ
66.1 (H2C-21), along with an OH-bearing methine H/C
at δ 4.51 (br. s, W1/2 = 12.0 Hz)/δ 67.6 (HC-3). The
H2C-21 (δ 4.17, 4.03) and HC-3 (δ 4.51) both showed
COSY correlations with the vicinal HC-2 (δ 1.98). More-
over, C-21 protons showed HMBC correlations with C-1
(δ 36.5), C-2 (δ 40.5) and C-3 (δ 67.6) (Figure 3a). Simi-
larly, C-20 methylene protons at δ 4.09, 3.82 exhibited
HMBC interactions with C-13 (δ 46.1), C-16 (δ 34.1),
and C-17 (δ 83.2). Stereochemistry at C-2 and C-3 was
deduced from the NOE correlations of HC-2 (δ 1.98)
with Me-19 (δ 0.87), and HC-3 (δ 4.51) with HC-5 (δ
2.01) (Figure 3b). On the basis of above observations,
the new metabolite was characterized as 2α,17α-di
(hydroxymethyl)-5α-androstan-3β-17β-diol (3).
The formula C20H34O3 for 4 (M
+ =m/z 322.2507,

























































Figure 1 Biotransformation of oxymetholone (1) by Macrophomina phaseolina (compounds 2, 3, 6, 7), Aspergillus niger (compounds 6,
7), Rhizopus stolonifer (compounds 3, 6) and Fusarium lini (compounds 2, 4, 5).
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indicated the absence of enone functionality. The 1H-
and 13C-NMR (Table 1) of metabolite 4 was substantially
different from that of the substrate 1, first due to the
lack of HC-21 olefinic methine signal, and second the
appearance of two new hydroxyl-bearing methine H/C
signals at δ 4.05 (m, W1/2 = 20.6 Hz)/δ 73.1 and 3.87 (m,
W1/2 = 20.6 Hz)/δ 76.7. Vicinal correlations between
H2C-1 (δ 2.27, 1.30), HC-2 (δ 4.05), HC-3 (δ 3.87) and
H2C-4 (δ 1.88, 1.72) in the COSY 45° spectrum indicated
the oxidative loss of C-21 methine. HC-2 (δ 4.05) and
HC-3 (δ 3.87) were also correlated to C-1 (δ 46.5), C-4
(δ 37.2), C-5 (δ 45.4), and C-10 (δ 37.6) in the HMBC
spectrum. The structure of new metabolite 4 was unam-
biguously established by single-crystal X-ray diffraction
analysis as half water solvate (Figure 4). It showed four
trans fused rings A, B, C, and D exist in chair/ chair/
chair, and envelop conformations, respectively. The C-2
and C-3 vicinal diols adopt equatorial orientations,
whereas hydroxyl and methyl substituents at C-17 were
found in pseudo-equatorial and pseudo-axial orienta-
tions, respectively. All bond angles and lengths were in
agreement with other related steroidal structures [8].
The molecular composition C21H30O3 was deduced
from the HREI-MS of metabolite 5 (M+ =m/z 330.2183,
calcd 330.2195), which was 2 amu less than the metabolite
2. The UV spectrum of 5 exhibited a λmax at 249.8 nm due
to extended conjugation in ring A. The 1H- and 13C-NMRspectra (Table 1) of metabolite 5 was distinctly similar to
2, indicating the presence of two olefinic H/C at δ 7.45
(s)/δ 150.0 (HC-1) and 6.28 (d, J = 1.0 Hz)/δ 124.0 (HC-4)
in ring A, along with hydroxy-methylene H2/C signals at δ
5.06, 4.98 (m)/δ 59.5 (H2C-21). The methine signals δ
6.28/δ 124.0 and methylene signals δ 5.06, 4.98/δ 59.5
showed similar HMBC correlations as those of HC-1 and
H2C-21 for metabolite 2. Similarly, C-4 proton (δ 6.28)
was correlated to C-3 (δ 186.0), C-5 (δ 169.4), C-6 (δ 32.5)
and C-10 (δ 43.5) in HMBC spectrum. The structure of
metabolite 5 was unambiguously deduced by single-crystal
X-ray diffraction studies (Figure 5). The asymmetric unit
contains two water solvated independent molecules of me-
tabolite 5. The ORTEP diagrams (Figure 5) showed that
compound 5 is consisting of four fused rings A , B, C
and D. Trans fused rings B, C and D adopt chair/chair
and envelop conformations, respectively, with the pseudo
equatorial orientation of hydroxyl substituent at C-17.
Ring A was found to be planner in geometry due to
extended conjugation. All the bond angles and lengths
were within the normal range as observed in previously
reported steroids [8].
The structure of known metabolite 6 was unambigu-
ously deduced through single-crystal X-ray diffraction
studies. ORTEP diagrams (Figure 6) showed that it con-
sists of trans fused rings A, B, C, and D with chair/
chair/chair and envelop conformations, respectively. The
hydroxymethylene moiety attached to C-2, and OH at
Table 1 1H- and 13C-NMR Chemical Shifts of New Compounds 2–5 (δ in ppm; J and W1/2 in Hz)
Position 2 3 4 5
1H 13C 1H 13C 1H 13C 1H 13C
1 6.48, s 152.4 1.63; 1.57, m 36.5 2.28, dd (12.5, 4.5); 1.30, m 46.6 7.45, s 150.0
2 - 137.5 1.98, m 40.5 4.05, m (W1/2 = 20.6 ) 73.1 - 137.6
3 - 199.0 4.51, br. s (W1/2 12.0) 67.6 3.86, m (W1/2 = 20.6 ) 76.7 - 186.0
4 2.47, dd (17.3, 4.2), 2.26, dd (17.3, 4.0) 41.6 1.71; 1.60 m 37.7 1.87 ddd (13.0, 5.0, 2.5); 1.72, m 37.2 6.28, s 124.0
5 1.83, m 44.8 2.01, m 39.6 1.26, m 45.3 - 169.4
6 1.32; 1.27, m 27.6 1.31; 1.25, m 28.8 1.28; 1.22, m 28.4 2.32, 2.21, m 32.5
7 1.71; 0.85, m 31.5 1.65; 0.90, m 32.4 1.65; 0.85, m 32.2 1.75; 0.85, m 33.7
8 1.44, m 36.7 1.44, m 36.4 1.37, m 35.9 1.57, m 36.3
9 0.78, m 50.7 0.76, m 54.9 0.67, m 54.7 0.81, m 52.9
10 - 38.9 - 36.6 - 37.6 43.5
11 1.63; 1.37, m 21.3 1.57; 1.29, m 21.0 1.62; 1.33, m 21.4 1.65; 1.55, m 22.9
12 1.61; 1.22, m 32.2 1.78; 1.49, m 32.7 1.58, 1.35, m 32.0 1.53; 1.14, m 31.8
13 - 46.3 - 46.1 - 46.2 - 46.2
14 1.20, m 51.2 1.37, m 51.8 1.24, m 51.0 1.12, m 50.2
15 1.53; 1.24, m 23.7 1.57; 1.34, m 24.2 1.54; 1.29, m 23.8 1.48; 1.30, m 23.8
16 2.14, ddd (13.5, 11.7, 3.5); 1.77, m 39.5 2.30, ddd (15.6, 9.2, 6.7); 1.95, m 34.1 2.13; 1.76, m 39.4 2.14, td (13.0, 3.5); 1.78, m; 39.2
17 - 80.5 - 83.2 - 80.6 - 80.3
18 1.08, s 14.9 1.14, s 15.2 1.06, s 14.8 1.08, s 14.8
19 0.96, s 13.1 0.87, s 12.5 0.89, s 13.7 1.15, s 18.8
20 1.41. s 26.8 4.09; 3.82, d (10.3) 67.3 1.40, s 26.7 1.37, s 26.6













Figure 2 Computer-generated ORTEP diagram of metabolite 2 (Hydrogens are omitted for clarity).
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orientations, respectively. All the bond angles and
lengths were found within normal range. Known metab-
olite 7 was structurally identified by comparing of its
spectral data with the one reported earlier.T-Cell proliferation inhibitory activity
Oxymetholone (1) is known to modulate cell-mediated
immunity in vivo. This was in part due to a decrease in
T-cell activity [5]. This initial observation prompted us
to investigate the T-cell proliferation inhibitory potential
of 1 and its metabolites.
Compounds 1–7 were evaluated for their effect on T-
cell proliferation by employing PHA to activate human
peripheral mononuclear cells (PBMC), isolated from the
blood sample from healthy human volunteers. The results
indicate that metabolite 6 possess more potent T-cell
proliferation inhibitory activity (IC50 = 2.7 μg/mL), as
compared to the substrate 1 (IC50 = 7.5 μg/mL) and stand-
ard prednisolone (IC50 < 3.1 μg/ mL) (Table 2, Figure 7);
whereas compounds 7 and 4 showed a moderate inhibi-
tory activity (IC50 = 10.6 ± 0.4 and 11.8 ± 0.9 μg/mL, re-
spectively). Compounds 2–5 showed a weak inhibition of
T-cell proliferation as compared to compounds mentioned
earlier. Limited SAR indicated that greater flexibility in
ring A, due to reduction of C = C or C =O bonds probably
contributes in activity.a
Figure 3 Important (a) HMBC, and (b) NOESY correlations in metaboliROS inhibition activity
Compounds 1–7 were also investigated for their effect on
ROS production by using whole blood and professional
phagocytic PMNs and the detecting probes luminal (Table 3,
Figures 8 and 9). Compound 2 showed slightly stronger
(p ≤ 0.005) inhibition (IC50 = 2.0 μg/mL) as compared to 1
(IC50 = 2.3 μg/mL). Both compounds were at least five fold
more active than the standard ibuprofen (IC50 = 11.2 μg/
mL) in whole blood phagocytes. Metabolite 7 showed a
moderate inhibitory activity (IC50 = 25.6 μg/mL), while
other compounds did not show any activity even at the
highest concentration (100 μg/mL). Compounds which
showed potent inhibitory activities were further evaluated
by using professional phagocytes PMNs. Compound 1
showed a significant inhibition of ROS generation in the
PMNs (IC50 = 6.3 μg/mL). Interestingly ROS generation in-
hibitory activity of compound 1 and its known metabolites
6 and 7 have not been studied before.
Cytotoxicity
Compounds 1–7 were found to be non-toxic towards
the normal mouse fibroblast (3T3) cells, even at the
highest concentrations tested (100 μg/mL).
Conclusions
Our study provides an efficient method for the production
of new anabolic steroids by the structural transformation of
oxymetholone (1) by using fungi. The procedure presentedb
te 3.
Figure 4 Computer-generated ORTEP diagram of metabolite 4 (Hydrogens are omitted for clarity).
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oxymetholone (1), as well as for the production of potential
immunomodulatory and anti-inflammatory drugs. In the
current study, compounds 2–7 found to posses a strong in-
hibitory effect on T-cell proliferation, with IC50 values be-
tween 31.2 to 2.7 μg/mL, while in case of the ROS
production, only compounds 1 and 2 exerted significant in-
hibition (IC50 ~ 2.0 μg/mL) on whole blood phagocytes.
Whereas only 1 showed significant ROS inhibition (IC50 =
6.3 μg/mL) on the isolated PMNs.
Experimental
General experimental conditions
Silica gel precoated plates (Merck, PF254; 20 × 20,
0.25 mm, Germany) were used for the TLC based separ-
ation. Silica gel (70–230 mesh, Merck) was used for col-
umn chromatography. Melting points were determined
with a Buchi-535, apparatus and are uncorrected. Optical
rotations were measured in methanol with a JASCO P-
2000 polarimeter. UV Spectra (in nm) were recorded in
methanol with a Hitachi U-3200 spectrophotometer.Figure 5 Computer-generated ORTEP diagram of metabolite 5 (HydroInfrared (IR) spectra (in cm-1) were recorded with an FT-
IR-8900 spectrophotometer. 1H- and 13C-NMR spectra
were recorded in C5D5N on a Bruker Avance NMR spec-
trometer, with residual solvent signal as the internal stand-
ard. Standard Bruker pulse sequences were used for 1D-
and 2D-NMR experiments. The chemical shifts (δ values)
are reported in parts per million (ppm), relative to TMS at
0 ppm. The coupling constants (J values) are reported in
Hertz. Electron impact (EI-MS), and high-resolution mass
spectra (HREI-MS) were recorded on JEOL JMS-600H
mass spectrometer (Japan); in m/z (rel.%). Single-crystal
X-ray diffraction data were collected on a Bruker Smart
APEX II diffractometer with CCD detector [17]. Data
reductions were performed by using SAINT program. The
structures were solved by direct methods [18], and refined
by full-matrix least squares on F2 by using the SHELXTL-
PC package [19]. The figures were plotted with the aid of
ORTEP program [20]. The luminometer used was from
Luminoskan RS (Labsystem Luminoskan, Helsinki, Fin-
land), and cell harvester and glass fiber filters used were
from Inotech (Dottikon, Swetzerland). Liquid scintillationgens are omitted for clarity).
Figure 6 Computer-generated ORTEP diagram of metabolite 6 (Hydrogens are omitted for clarity).
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http://journal.chemistrycentral.com/content/6/1/153counter used was LS65000 from Beckman Coulter (Fuller-
ton, CA, USA). Microplate reader used was SpectraMax
(Molecular Devices, CA, USA).
The chemicals and reagents were purchased from the
following sources: Oxymetholone (1) (TCI, Japan),
Luminol (Research Organics, OH, USA), Hanks balance
salts solution (HBSS), phytohemagglutinin-L (PHA-L),
penicillin, and streptomycin (Sigma,St. Louis, USA), lym-
phocytes separation medium (LSM) (MP Biomedicals,
Illkirch, France), zymosan-A (Saccharomyces cerevisiae)
(Fluka BioChemika, Buchs, Switzerland), tritiated thymi-
dine (Amersham Pharmacia Biotech, UK) and 3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide
(MTT) (Amresco, Solon, OH, USA).
Tissue culture plates were obtained from Iwaki (Japan).
Mouse fibroblasts (3T3) were obtained from the European
American Culture Collection (EACC). Dulbcco’s modified
eagle medium (DMEM) and fetal bovine serum were pur-
chased from Gibco-BRL (Grand Island, NY, USA).Microorganisms and culture medium
The fungi were obtained either from the Northern Regional
Research Laboratories (NRRL), or Karachi University CultureTable 2 Inhibitory effect of compounds on the T-cell
proliferation in comparison to standard
Compound IC50 μg/mL
a)
1 7.5 ± 0.4
2 17.4 ± 1.2
3 17.0 ± 1.2
4 11.8 ± 0.9
5 31.2 ± 1.9
6 2.7 ± 0.2
7 10.6 ± 0.4
Standard (Prednisolone) < 3.1
a)Each IC50 value represents the mean value of triplicate reading ± SD.Collection (KUCC) or American Type Culture Collection
(ATCC).
Macrophomina phaseolina (KUCC 730) and Fusarium
lini (NRRL 2204) were grown in a medium composed of
the following ingredients and dissolved in distilled H2O
(4.0 L): glucose (40.0 g), glycerol (40.0 mL), peptone
(20.0 g), yeast extract (20.0 g), KH2PO4 (20.0 g), and NaCl
(20.0 g). The media (2.0 L) for Aspergillus niger (ATCC
10549), and Rhizopus stolonifer (ATCC 10404) were the
same as above, except addition of glycerol (10.0 mL) for A.
niger and yeast extract (6.0 g) for R. stolonifer.
General fermentation and extraction conditions
The fungal medium was distributed into 250 mL conical
flasks (100 mL each) and autoclaved at 121°C. Mycelia
of the fungi were transferred to flasks and incubated at
26 ± 2°C for two-three days on rotary shaking (120 rpm).
Compound 1, dissolved in acetone, was evenly distribu-
ted among all the flasks which were placed on the rotary
shaker (120 rpm) at 26 ± 2°C for fermentation. Parallel
control experiments were conducted which included an
incubation of the fungus without substrate 1, and an in-
cubation of 1 in the medium without fungus. The degree
of transformation was analyzed on TLC after one day.
The culture medium and mycelium were separated by
filtration. The mycelium was washed with dichloro-
methane (CH2Cl2, 1.0 L). The aqueous filtrate was
extracted with CH2Cl2 (4 L × 3). The CH2Cl2 extract was
dried over anhydrous Na2SO4, evaporated under reduced
pressures, and the resulting brown gum was analyzed by
thin-layer chromatography. The control flasks were also
harvested in the same manner, and compared with the
test to assure the presence of biotransformed products.
Fermentation of oxymetholone (1) with Macrophomina
phaseolina
Oxymetholone (1; 800 mg) was dissolved in 20 mL acet-

























50 µg/mL 5 µg//mL 0.5 µg//mL
Figure 7 Effect of compounds 1–7 on phytohemagglutinin (PHA) activated T-cell proliferation. The effect of compounds on the T-cell
proliferation is compared with control. Each bar represents the mean value of triplicate reading ± SD
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ried out for twelve days. The gummy material (2.5 g),
obtained after filtration, extraction and evaporation, was
loaded onto a silica gel column for fractionation. The
mobile phase was composed of pet. ether and acetone
with a gradient of 10%. Three main fractions (OX-1 − 3)
were obtained on the basis of TLC analysis. Fraction
OX-1 yielded metabolites 2 (07 mg) and 6 (43 mg) on
elution from silica gel column (pet. ether: acetone = 9:1),
while OX-2, when subjected to silica gel column chro-
matography, yielded metabolite 7 (21 mg, pet. ether:
acetone = 8:2). Fraction OX-3 yielded metabolite 3
(276 mg, pet. ether: acetone = 7:3) after elution from sil-
ica gel column.17β-Hydroxy-2-(hydroxymethyl)-17α-methyl-5α-androstan-
1-en-3-one (2)
Colorless crystalline solid; m.p. 173–174°C; [α]25D -45.4 (c
0.03, MeOH); UV (MeOH): λmax nm (log ε) 236.4 (3.9);
IR (KBr): νmax: 3358, 1666, 1629, 1095 cm
-1; 1H-NMR:
(500 MHz, C5D5N) see Table 2;
13C-NMR: (125 MHz,
C5D5N) see Table 2; EI-MS (%): m/z 332 (M
+, 30), 274
(25), 216 (20), 176 (39), 174 (52), 161 (34), 147 (24), 123
(32), 108 (31), 91 (56), 71 (100), 55 (95); HREI-MS: m/zTable 3 Inhibitory effects of compounds on ROS production i
Compound IC50 μg/mL
a) (Whole B
1 2.3 ± 0.0






Standard (Ibuprofen) 11.2 ± 1.9
a)Each IC50 value represents the mean value of triplicate reading ± SD.332.2333 (M+ [C21H32O3]
+, calcd 332.2351). Crystal
data: empirical formula = C21H32O3, Mr = 332.47, ortho-
rhombic, space group P212121, a = 7.715 (4) Å, b =
13.604 (7) Å, c = 36.769 (16) Å, V = 3859 (3) Å3, Z = 8,
ρcalc = 1.145 mg m
-3, F(000) = 1456, μ (Mo Kα) =
0.71073 Å, max/min transmission 0.9948/0.9867, crystal
dimensions 0.18 × 0.13 × 0.07 mm, 1.11° < θ < 25.50°,
22,826 reflections were collected, out of which 4,091
reflections were observed (Rint = 0.1228) and 433 para-
meters were refined. The R-values were; R1 = 0.0610,
wR2 = 0.1293 for I > 2σ (I), and R1 = 0.1210, wR2 = 0.1691
for all data, max/min residual electron density; 0.226/-
0.229 e Å-3. Crystallographic data for compound 2 can
be obtained from the Cambridge Crystallographic Data
Center, through the allocated deposition code CCDC
795529 (Additional file 1 and Additional file 2).2α,17α-Di(hydroxymethyl)-5α-androstan-3β-17β-diol (3)
Amorphous material; [α]25D -14.3 (c = 0.03, MeOH); IR
(KBr): νmax 3382, 1381 cm
-1. 1H-NMR: (600 MHz,
C5D5N) see Table 3;
13C-NMR: (150 MHz, C5D5N) see
Table 3; EI-MS (%): m/z 352 (M+, 6), 334 (26), 316 (14),
303 (72), 285 (100), 260 (55), 245 (49), 229 (23), 177
(23), 161 (33), 147 (37), 107 (47), 93 (42), 55 (26); HREI-n human whole blood and PMNs










Figure 8 Effect of compounds 1–7 on reactive oxygen species (ROS) production using whole blood phagocytes. The compounds activity
was compared with the control (C = cells with activator). Each plot and error bar represents reading ± SD of three repeats
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Colorless crystalline solid; m.p. 197–199°C. [lit. 198–200°C]
[15]; [α]25D +13.5 (c 0.04, MeOH) [lit. +19.7]. Crystal data:
empirical formula = C21H34O3, Mr = 334.48, orthorhombic,
space group P212121, a = 7.3859 (3) Å, b = 20.6898 (9) Å,
c = 12.4157 (6) Å, V = 1897.27 (15) Å3, Z = 4, ρcalc =
1.171 mg m-3, F(000) = 736, μ (Mo Kα) = 0.71073 Å, max/
min transmission 0.9962/0.9754, crystal dimensions 0.33 x
0.21 x 0.05 mm, 1.64° < θ < 27.50°, 18840 reflections were
collected, out of which 4479 reflections were observed
(Rint = 0.0422) and 437 parameters were refined. The
R-values were; R1 = 0.0534, wR2 = 0.1354 for I > 2σ (I),


































50 µg/mL 5 
Figure 9 Effect of compounds 1 and 3–7 on reactive oxygen species
activity was compared with the control (C = cells with activator). Each plotresidual electron density; 0.433/-0.214e Å-3. Crystallo-
graphic data for compound 6 can be obtained from the
Cambridge Crystallographic Data Center (code CCDC
795530) (Additional file 4 and Additional file 5).2α-(Hydroxymethyl)-17α-methyl-5α-androstan-3β-17β-diol (7)
Colorless crystalline solid; m.p. 279–281°C. [lit. 280–282°C]
[15]; [α]25D -25.4 (c 0.02, MeOH) [lit. – 37.0] (Additional file 6).Fermentation of oxymetholone (1) with Aspergillus niger
and Rhizopus stolonifer
Incubation of 1 (400 mg/10 mL acetone) with 2 days old
culture of A. niger in 20 flasks for 6 days produced the
previously isolated metabolites 6 (64 mg) and 7 (136 mg),
while R. stolonifer (20 flasks) transformed 1 (400 mg/
10 mL acetone) into metabolites 3 (86 mg) and 6 (15 mg).5 6 7 C
µg/mL 0.5 µg/mL
(ROS) production using isolated neutrophils. The compounds
and error bar represents reading ± SD of three repeats
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http://journal.chemistrycentral.com/content/6/1/153Fermentation of oxymetholone (1) with Fusarium lini
Incubation of 1 (600 mg/15 mL acetone) with 2-day old F.
lini culture in 30 flasks for 12 days produced three metabo-
lites which were purified by silica gel column chromatog-
raphy to obtain metabolites 2 (146 mg), 4 (32 mg, pet.
ether: acetone = 7:3) and 5 (15 mg, pet. ether: acetone = 7:3).17α-Methyl-5α-androstan-2α,3β-17β-triol (4)
Colorless crystalline solid; m.p.: 124–125°C. [α]25D : -29.0
(c = 0.01, MeOH). IR (KBr): νmax 3409, 2927, 1051 cm
-1;
1H-NMR: (500 MHz, C5D5N) see Table 3;
13C-NMR:
(125 MHz, C5D5N) see Table 3; EI-MS (%): m/z 322 (M
+,
98), 307 (100), 304 (43), 264 (39), 249 (95), 229 (30), 215
(53), 181 (54), 171 (58), 169 (51), 123 (55), 109 (33), 95
(41), 81 (40), 57 (30), 43 (42); HREI-MS: m/z 322.2507 (M+
[C20H34O3]
+, calcd 322.2508); Crystal data: empirical for-
mula = C20H35O4 [C20H34O3·OH], Mr = 339.48, mono-
clinic, space group P21, a = 11.5169 (19) Å, b = 6.7843 (12)
Å, c = 12.820 (2) Å, V = 945.6 (3) Å3, Z = 2, ρcalc =
1.192 mg m-3, F(000) = 374, μ (Mo Kα) = 0.71073 Å, max/
min transmission 0.9912/0.9785, crystal dimensions 0.27 ×
0.12 × 0.11 mm, 1.68° < θ < 25.50°, 4,363 reflections were
collected, out of which 1,585 reflections were observed
(Rint = 0.0493) and 221 parameters were refined. The R-
values were; R1 = 0.0452, WR2 = 0.0808 for I > 2σ (I),
and R1 = 0.0791, WR2 = 0.0914 for all data, max/min
residual electron density; 0.147/-0.141 e Å-3. Crystallo-
graphic data for compound 4 can be obtained from the
Cambridge Crystallographic Data Center (code CCDC
795528) (Additional file 7 and Additional file 8).17β-Hydroxy-2-(hydroxymethyl)-17α-methylandrost-1,4-
dien-3-one (5)
Colorless crystalline solid; m.p. 163–164°C; [α]25D -33.0 (c =
0.01, MeOH); UV (MeOH): λmax nm (log ε): 249.8 (4.0). IR
(KBr): νmax 3402, 1664, 1620, 1082, 1033 cm
-1. 1H-NMR:
(500 MHz, C5D5N) see Table 3.
13C-NMR: (125 MHz,
C5D5N) see Table 3. EI-MS (%): m/z 330 (M
+, 35), 312
(19), 294 (13), 254 (17), 161 (24), 152 (76), 147 (29), 134
(100), 121 (34), 107 (18), 91 (14). HREI-MS: m/z 330.2183
(M+, [C21H30O3]
+; calcd 330.2195). Crystal data: empirical
formula = C42H62O8, Mr= 694.92, monoclinic, space group
P21, a = 7.7609 (5) Å, b = 13.2141 (8) Å, c = 18.6769 (11)
Å, V = 1913.9 (2) Å3, Z = 2, ρcalc = 1.206 mg m
-3, F(000) =
756, μ (Mo Kα) = 0.71073 Å, max/min transmission
0.9879/0.9751, crystal dimensions 0.31 × 0.17 × 0.15 mm,
1.09° < θ < 25.00°, 10,983 reflections were collected, out
of which 3,534 reflections were observed (Rint = 0.0364)
and 458 parameters were refined. The R-values were;
R1 = 0.0523, wR2 = 0.1342 for I > 2σ (I), and R1 = 0.0699,
wR2 = 0.1544 for all data, max/min residual electron dens-
ity; 0.320/-0.311 e Å-3. Crystallographic data for compound
5 can be obtained from the Cambridge CrystallographicData Center (code CCDC 799213) (Additional file 9 and
Additional file 10).
T-Cell proliferation inhibition assay
Peripheral blood mononuclear cells (PBMC) were iso-
lated from heparinized venous blood of healthy adult
donors by Ficoll–Hypaque gradient centrifugation [21].
Cells were proliferated as reported earlier [22]. Briefly,
cells were cultured at a concentration of 2 × 106/mL in a
96-well round bottom tissue culture plate. Cells were sti-
mulated with 5 μg/mL of phytohemagglutinin. Various
concentrations of compounds were added to obtain final
concentrations of 0.5, 5, 50 μg/mL, each in triplicate.
The plate was incubated for 72 h at 37°C in 5% CO2 en-
vironment. After 72 h, cells were pulsed with 0.5 μCi/
well, tritiated thymidine, and further incubated for 18 h.
Cells were harvested onto a glass fiber filter by using cell
harvester. The tritiated thymidine incorporation into the
cells, which reflects the proliferation level, was measured
by a liquid scintillation counter.
Phagocyte chemiluminescence assay
Luminol-enhanced chemiluminescence assay was per-
formed according to the previous reported method [23].
Briefly 25 μL of whole blood or neutrophils (1 × 106/mL),
suspended in Hank’s solution, were incubated with 25 μL
compounds (1, 10, 100 μg/mL for whole blood and 0.5, 5,
50 μg/mL for neutrophils) for 30 min. Zymosan 25 μL
(20 mg/mL), followed by 25 μL (7 × 10-5 M) of luminol
was added to make a final volume of 100 μL. A control
without the compound was also run. Peak chemilumines-
cence was recorded using the luminometer. The lumin-
ometer was set with repeated scan mode, 50 scans with
30 s intervals and one second point measuring time.
Cytotoxicity assay
The cytotoxicity of compounds was determined by using
the MTT cellular assay [24, 25] against a normal mouse
fibroblast (3T3) cell line. Cells were grown in DMEM and
MEM (modified Eagle’s medium), containing 10% FBS
and 2% antibiotic (penicillin and streptomycin), and main-
tained at 37°C in 5% CO2 for 24 hours in a flask. Cells
were plated (1 × 105 cell/mL) in 96-well flat bottom plates
and incubated for 24 hours for cell attachment. Various
concentrations of compounds, ranging between 1.25-
100 μM, were added into the well and incubated for
48 hours. A 50 μL [2 mg/mL] MTT, 3-(4,5-dimethylthia-
zol-2-yl)-2,5-diphenyltetrazolium bromide was added to
the well, 4 hours before the end of incubation. Medium
and reagents were aspirated and 100 μL DMSO was added
and mixed thoroughly for 15 minutes to dissolve the for-
mazan crystals. The absorbance was measured at 570 nm
by using a microplate reader. Finally, IC50 (μM) values
were calculated, and the experiment was repeated at least
Khan et al. Chemistry Central Journal 2012, 6:153 Page 11 of 11
http://journal.chemistrycentral.com/content/6/1/153three times. Cycloheximide was used as the standard for
normal fibroblast cell line.
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Additional file 1: Spectroscopic data of compound 2. Include spectra
of 1H-NMR, EI-MS, HREI-MS, IR, and UV experiments.
Additional file 2: Crystallographic information file (cif) of compound 2.
Additional file 3: Spectroscopic data of compound 3. Include spectra
of 1H-NMR, 13C-NMR (BB, DEPT-135), HSQC, HMBC, COSY-45°, NOESY, EI-
MS, HREI-MS, and IR experiments.
Additional file 4: Spectroscopic data of compound 6. Include spectra of
1H-NMR, 13C-NMR (BB, DEPT-135), HMQC, HMBC, COSY-45°, NOESY, and EI-MS.
Additional file 5: Crystallographic information file (cif) of compound 6.
Additional file 6: Spectroscopic data of compound 7. Include spectra of
1H-NMR, 13C-NMR (BB, DEPT-135), HMQC, HMBC, COSY-45°, NOESY, and EI-MS.
Additional file 7: Spectroscopic data of compound 4. Include spectra
of 1H-NMR, 13C-NMR (BB, DEPT-135), HSQC, HMBC, COSY-45°, NOESY,
EI-MS, HREI-MS, IR and UV experiments.
Additional file 8: Crystallographic information file (cif) of compound 4.
Additional file 9: Spectroscopic data of compound 5. Include spectra
of 1H-NMR, 13C-NMR (BB, DEPT-135), HSQC, HMBC, COSY-45°, NOESY,
EI-MS, HREI-MS, and IR experiments.
Additional file 10: Crystallographic information file (cif) of compound 5.
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